Stay updated on Odanacatib Study in Adolescents Clinical Trial
Sign up to get notified when there's something new on the Odanacatib Study in Adolescents Clinical Trial page.

Latest updates to the Odanacatib Study in Adolescents Clinical Trial page
- Check4 days agoChange DetectedFooter updates: added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.3.2 is now shown on the page, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the government funding lapse notice about NIH/OPM operating status, which was ancillary to the page content and did not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedScreenshots show no substantive changes to the study record’s core content; only minor UI/formatting differences are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedUpdates the page to reflect new operating status and version (v3.2.0) and removes the old version (v3.1.0).SummaryDifference3%

- Check89 days agoChange DetectedUpdated version tag to v3.1.0 and removed several drug-safety topic sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); retains the prior version reference v3.0.2.SummaryDifference0.4%

Stay in the know with updates to Odanacatib Study in Adolescents Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Odanacatib Study in Adolescents Clinical Trial page.